obtained from ATCC and were cultured in Dulbecco’s modified
Eagle medium + 10% FBS at 37 °C calcium and 5% CO2 level. To test PPT1 inhibition in cells, HepG2 cells were seeded
in 6-well plates and left overnight to adhere. The following day,
compounds were added to cell culture media and incubated for 5 h,
followed by cell lysis and protein extraction. The MPER extraction
agent (Thermo Fisher Scientific) along with the Halt protease inhibitor
(Thermo Fisher Scientific) in 0.5% Triton X100 were used for cell
lysis followed by centrifugation at 14,000 rpm for 15 min to obtain
cell lysates. Lysates were normalized for protein amount and 5 μL
of cell lysates were used for the PPT1 assay as described earlier
with modifications.42 (link),47 (link) 4-methylumbelliferone (4-MU)
(Sigma-Aldrich) was used to make a standard curve. Fluorescence intensity
was measured using a SpectraMax iD5 plate reader (Molecular Devices).
For testing PPT1 inhibitor activity in cell lysates, 50 μL of
HepG2 cell lysates were treated with the compounds for an hour, followed
by enzyme inhibition using the PPT1 enzyme assay as above. Experiments
were performed in biological duplicates containing technical replicates
in triplicates. The percent PPT1 activity was determined relative
to that of the DMSO control.